Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pegbovigrastim

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Simple Summary The innate and adaptive immune system of dairy cows is impaired during the transition period, leading to an… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
2019
2019
In the present study, we aimed to investigate the side effects of pegbovigrastim, injected approximately 7 d before parturition… Expand
2019
2019
BackgroundMycoplasma bovis is a causative agent of disease in cattle causing many clinical conditions. Currently there are no… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2019
2019
The objective of this study was to evaluate the effect of pegbovigrastim (PEG) treatment of peripartum Holstein cows on the… Expand
2019
2019
Simple Summary During the transition period (TP), the innate and adaptive immune system of dairy cows is impaired, contributing… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
2018
2018
Previous research in various species has shown that granulocyte-colony stimulating factor stimulates the production and release… Expand
  • table 1
  • figure 1
2018
2018
Treatment with granulocyte colony-stimulating factor has been reported to increase circulating neutrophil count and enhance… Expand
2017
2017
Treatment with granulocyte colony-stimulating factor (G-CSF) increases polymorphonuclear cell (neutrophil) count and enhances… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2017
2017
Periparturient dairy cows experience impaired immune function, exhibited as a transient decrease in neutrophil function. This… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
2017
2017
This study analyzed the efficacy of pegbovigrastim (Imrestor, Elanco Animal Health, Greenfield, IN) on some health and production… Expand
  • figure 1
  • figure 2
  • table 3
  • figure 3
  • table 2